Pedal power: could indoor cycling delay Alzheimer's in At-Risk seniors?

NCT ID NCT04748861

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study looks at whether long-term, high-intensity indoor cycling can slow or delay Alzheimer's-related brain changes in healthy older adults (ages 65-80) who carry the APOE ε4 gene, a known risk factor. Participants, who are currently inactive, will use a Peloton bike at home. Researchers will measure memory, brain volume, and fitness to see if exercise makes a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

Oct 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Healthy elders, ages 65-80 years, inclusive 2. No cognitive impairment based on screening examination 3. APOE ε4 genotype 4. Inactive; defined as exercising less than 3x per week at moderate-vigorous intensity 5. Fluent in English (a requirement for neurocognitive testing) 6. Does not plan to travel for more than 2 consecutive weeks over the course of the study 7. Demonstrate ability to safely mount and dismount Peloton stationary cycle 8. In-home Wi-Fi (Peloton system requires Wi-Fi to transmit exercise data) 9. Medical clearance by the study doctor to participate in exercise program 10. Participant must meet Peloton height and weight safety requirements Exclusion Criteria: 1. Any significant neurologic disease, including dementia, mild cognitive impairment, Parkinson's disease, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, stroke, multiple sclerosis, or history of significant head trauma with a reported loss of consciousness for greater than 30 minutes. 2. Significant medical illnesses/conditions that is unstable and/or uncontrolled (lung or kidney disease, cancer). 3. History of schizophrenia or bipolar disorder. 4. Major Depression within the past year. 5. History of alcohol or substance abuse or dependence within the past 2 years. 6. Current use of Alzheimer's disease medications, including cholinesterase inhibitors and memantine. 7. Any unstable or severe cardiovascular disease or asthmatic condition. 8. History of imaging confirmed transient ischemic attack or a score of \>4 on the modified Hachinski ischemic scale. 9. Significant abnormalities in laboratory blood tests that is considered to be a contraindication to exercise. 10. Exclusion criteria specific to MR scanning (weight inappropriate for height, ferrous objects within the body, pregnancy, and a history of claustrophobia). 11. A musculoskeletal issue (arthritis, osteoporosis, back problem) that would limit one's ability to engage in exercise

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Exercise intervention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic

    Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.